There are many drug target classes for which unwanted on-target pharmacology limits clinical application. Understanding E3 tissue expression across both healthy and diseased tissues enables a disease-directed TPD strategy based …
A key step in the targeted protein degradation (TPD) process is the formation of an induced proximity complex, where a degrader molecule recruits an E3 ligase to the protein of …
In contrast to the discovery of "traditional drugs" such as small molecule inhibitors and most biologics, the development of protein degraders presents unique challenges as degraders are acting with an …
Today, Insilico Medicine, a leading player in artificial intelligence (AI)-driven drug discovery and longevity research, tops up its recent $60 million Series D with additional $35 million from Prosperity7 Ventures, …
Cyclica is designing chemical probes for DCAF1, a potentially novel target for protein degradation, with proprietary technology MatchMaker DCAF1 was originally identified as a putative antiviral host target and more …
Bioz provides advanced life science experimentation insights to scientists in two key formats, first on the Bioz platform which showcases over 300 million products from 50,000 vendors, and second via …
Sponsored by Biocompare.com Every marketer feels pressure to demonstrate results for their marketing spend. Executives in the life sciences industry demand accountability for budget expenditures. The problem, of course, is …
This is a sponsored case study republished from ScienceExchange.com Over the past decade, the biopharmaceutical industry has undergone a massive shift — one that is only accelerating as global pressures …
There is a new generation of tech-savvy drug discovery companies, applying the power of artificial intelligence (AI) to accelerate and improve the most important stages of bringing a new drug …
There is a new wave of innovation that is sweeping through pharmaceutical drug discovery: targeted protein degradation (TPD). TPD is the process of targeting a disease-causing protein for destruction. In …
The application of Artificial Intelligence (AI) to accelerate and improve drug discovery has been a growing trend for several years in a row, with the increasing number of AI-inspired drug …
High-Resolution Ion Mobility Mass Spectrometry (HRIM-MS) has emerged as a promising new separations technique in the biopharmaceutical and clinical market. In this interview, Dr. Melissa Sherman, CEO of MOBILion Systems …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.